Literature DB >> 16352089

Blalock-Taussig shunt: experience from the developing world.

Jamal S Rana1, Kaashif A Ahmad, Aliya S Shamim, Sulaiman B Hassan, Mehnaz A Ahmed.   

Abstract

BACKGROUND: Palliative procedures have a role in congenital cardiac malformations that do not permit a complete early repair, and in centres where facilities for complete early repair do not exist. The lack of data on modified Blalock-Taussig shunt from developing countries prompted this analysis.
METHODS: We report a retrospective study of 70 Blalock-Taussig shunt procedures in 63 patients over an 8-year period. Most of the procedures (54.0%) were done on children less than 4 months of age. Thirty-nine (58%) patients had Tetralogy of Fallot; the remaining patients had a wide spectrum of lesions.
RESULTS: In the first year of the review period, the classical Blalock-Taussig shunt was done in six patients (9.5%) and the modified Blalock-Taussig shunt was used thereafter. In 49 patients who were followed up long term, clinical congestive cardiac failure developed in three (6%) and shunt failure was reported in 10 (14%). Of the 16 (33%) total deaths, six had serious comorbid conditions preoperatively.
CONCLUSIONS: The Blalock-Taussig shunt is a relatively safe palliative procedure, requiring fewer resources and less expertise than corrective surgery, making it a suitable option in developing countries.

Entities:  

Year:  2002        PMID: 16352089     DOI: 10.1046/j.1444-2892.2002.00145.x

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  2 in total

1.  Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt.

Authors:  Mehmet Küçük; Rahmi Özdemir; Mustafa Karaçelik; Önder Doksöz; Cem Karadeniz; Yılmaz Yozgat; Timur Meşe; Nejat Sarıosmanoğlu
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

2.  Effects of protocol-based management on the post-operative outcome after systemic to pulmonary shunt.

Authors:  Sameh R Ismail; Muneira M Almazmi; Rajab Khokhar; Wedad AlMadani; Ali Hadadi; Omar Hijazi; Mohamed S Kabbani; Ghassan Shaath; Mahmoud Elbarbary
Journal:  Egypt Heart J       Date:  2018-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.